RocketTickers

MeiraGTx Announces AAV-CNGA3 Has Received Orphan Drug Designatio

Long
NASDAQ:MGTX   MeiraGTx Holdings plc
MGTX: MeiraGTx Holdings Plc
2018-08-13 07:00:00
MeiraGTx Announces AAV-CNGA3 Has Received Orphan Drug Designation from the U.S. FDA for the Treatment of Achromatopsia
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.